Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 23.55
+0.15 (0.64%)
Apr 8, 2026, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 541.01 million as of April 8, 2026. Its market cap has increased by 17.12% in one year.
Market Cap
541.01M
Enterprise Value
529.23M
Revenue
87.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.55
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 541.01M, an increase of 857.49%. That is a compound annual growth rate of 16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 541.01M | -13.65% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 442.30M |
| Bioceltix | 421.04M |
| BIOTON | 365.78M |
| Synthaverse | 256.19M |
| Mabion | 138.35M |
| Molecure | 108.58M |
| NanoGroup | 81.09M |
| Poltreg | 79.28M |